KTTA - Pasithea Therapeutics to Participate in H.C. Wainwright 25th Annual Global Investment Conference | Benzinga
-- Attendees may request 1 x 1 meeting with management at meetings@hcwco.com --
PALO ALTO, Calif. and MIAMI, Fla., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ:KTTA) ("Pasithea" or the "Company"), a biotechnology company focused on the discovery, research, and development of innovative treatments for central nervous system (CNS) disorders, announced today that Pasithea's management team will participate in the H.C. Wainwright 25th Annual Global Investment Conference, to be held in New York City, September 11-13.
Attendees interested in 1 x 1 meetings are invited to request them through the ...